GoodRx Holdings reported quarterly EPS of $0.07, matching the Zacks Consensus Estimate and down from $0.09 a year ago. The release is broadly neutral, with no earnings surprise but a modest year-over-year decline in profitability.
GoodRx Holdings reported quarterly EPS of $0.07, matching the Zacks Consensus Estimate and down from $0.09 a year ago. The release is broadly neutral, with no earnings surprise but a modest year-over-year decline in profitability.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
